Previous studies have demonstrated that platelet activation occurs in patients with pulmonary arterial hypertension (PAH). Mean platelet volume (MPV) and platelet distribution width (PDW) are two markers of platelet activation, and have recently been recognised as risk predictors of cardiovascular diseases. This study aimed to investigate whether MPV and PDW would be useful to reflect disease severity and predict prognosis in idiopathic PAH (IPAH).
MPV and PDW levels were measured in 82 IPAH patients without antiplatelet or anticoagulant treatment on admission and 82 healthy controls. Concurrent collected data included clinical, haemodynamic and biochemical variables. All patients were followed-up from the date of blood testing. The endpoint was all-cause mortality.
MPV and PDW were significantly higher in patients with IPAH than in age and sex-matched control subjects (11.4 ± 0.9fl vs. 10.3 ± 0.9fL and 14.3±2.9% vs. 11.9±1.9%, respectively; p = 0.000). Pearson's correlation analysis revealed that MPV and PDW correlated positively with right ventricular systolic pressure, mean pulmonary arterial pressure and pulmonary vascular resistance. After a mean follow-up of 14±8 months, 12 patients died of right heart failure. Receiver operating characteristic analysis showed that MPV and PDW could not predict all-cause mortality. Multivariate Cox regression analysis suggested that right/left ventricular end-diastolic diameter ratio and NT-proBNP were independent predictive parameters of all-cause mortality.
Our results suggest that MPV and PDW were elevated in patients with IPAH. They could partly reflect disease severity, but did not predict prognosis.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities.Int J Cardiol. 2011; 147: 4-12
- The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model.Blood. 2010; 116: 1613-1622
- Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.Blood. 2007; 110: 2166-2172
- Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.Inflammation. 2014; 37: 100-106
- Mean platelet volume and coronary artery disease: a systematic review and meta-analysis.Int J Cardiol. 2014; 175: 433-440
- Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention.Journal of the American College of Cardiology. 2005; 46: 284-290
- Platelet indices in patients with pulmonary arterial hypertension.Clinical and Applied Thrombosis/hemostasis. 2011; 17: E171-E174
- Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study.Thrombosis Research. 2010; 126: 280-282
- Mean platelet volume levels predict pulmonary artery hypertension in patients with atrial septal defect.Acta Cardiologica. 2014; 69: 161-166
- Guidelines for the diagnosis and treatment of pulmonary hypertension.European Heart Journal. 2009; 30: 2493-2537
- Mean platelet volume as an indicator of platelet activation: methodological issues.Platelets. 2002; 13: 301-306
- Platelet activation: assessment and quantification.European Heart Journal. 2001; 22: 1561-1571
- Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease.British Journal of Haematology. 2002; 117: 399-404
- Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.Cardiology Journal. 2013; 20: 491-498
- Large platelets circulate in an activated state in diabetes mellitus.Semin Thromb Hemost. 1991; 17: 433-438
- Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis.Clinical and Laboratory Haematology. 1992; 14: 281-287
- Mean platelet volume as an inflammatory marker in patients with severe periodontitis.Platelets. 2014; ([Epub ahead of print])
- Evaluation of mean platelet volume (MPV) levels in patients with synovitis associated with knee osteoarthritis.Platelets. 2014; 25: 81-85
- Mechanisms of disease: pulmonary arterial hypertension.Nature Reviews Cardiology. 2011; 8: 443-455
- Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.Circulation. 2000; 102: 2720-2725
- Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension.Angiology. 1993; 44: 701-706
- Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay.Circulation. 2014; 129: 1332-1340
- Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.Circulation research. 2014; 115: 165-175
- The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.Chest. 2009; 135: 794-804
- Platelet activation by collagen provides sustained release of anabolic cytokines.The American Journal of Sports Medicine. 2011; 39: 729-734
- Reversal of experimental pulmonary hypertension by PDGF inhibition.The Journal of Clinical Investigation. 2005; 115: 2811-2821
Published online: December 09, 2014
Accepted: November 27, 2014
Received in revised form: November 12, 2014
Received: September 10, 2014
© 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier Inc. All rights reserved.